Cost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis

Figure 2

Trends in cost-effectiveness ratios between the bariatric surgery and conventional medication therapy group over 40 cycles. Cumulative eff. in the bariatric surgery therapy group was always higher than cumulative eff. in the conventional medication therapy group. In the middle of the cycle 10 and cycle 11, cumulative cost in the bariatric surgery therapy group and conventional medication therapy group began to cross.